Welcome to Natrecor360.com, where healthcare professionals can find helpful tools, resources and NATRECOR® product information.

NATRECOR® (nesiritide) is indicated for the intravenous treatment of patients with acutely decompensated congestive heart failure who have dyspnea (shortness of breath) at rest or with minimal activity. In this population, the use of NATRECOR® reduced pulmonary capillary wedge pressure (PCWP) and improved dyspnea.


This site is intended for US healthcare professionals. If you are a patient or family/friend of a patient and want information on NATRECOR® and ADHF, please visit www.natrecor.com.